The largest purchase of all time was on 2018-09-10 and amounted to 2117648 shares of KalVista Pharmaceuticals, Inc. for $36M.
The largest sale of all time was on 2023-09-11 and amounted to 18000 shares of KalVista Pharmaceuticals, Inc. for $189,050.
No biography is available at this moment.
| 2023-09-11 | Sale | KalVista Pharmaceuticals, Inc. KALV | director | 18,000 0.0521% | $10.50 | $189,050 | +12.43% | |
| 2020-10-30 | KalVista Pharmaceuticals, Inc. KALV | director | 115,686 0.647% | $17.24 | $1.99M | +18.83% | ||
| 2019-07-29 | KalVista Pharmaceuticals, Inc. KALV | director | 29,867 0.1734% | $17.13 | $511,702 | -27.21% | ||
| 2019-07-26 | KalVista Pharmaceuticals, Inc. KALV | director | 26,500 0.1507% | $16.83 | $446,035 | -26.89% | ||
| 2019-07-19 | KalVista Pharmaceuticals, Inc. KALV | director | 60,000 0.3481% | $17.81 | $1.07M | -29.4% | ||
| 2019-07-17 | KalVista Pharmaceuticals, Inc. KALV | director | 1,280 0.0072% | $16.96 | $21,715 | -28.47% | ||
| 2018-09-10 | KalVista Pharmaceuticals, Inc. KALV | director | 2.12M 14.0828% | $17.00 | $36M | +17.02% | ||
| 2018-01-25 | VYNE Therapeutics Inc. VYNE | director | 588,236 1.9809% | $17.00 | $10M | -71.72% | ||
| 2017-05-09 | Biohaven Pharmaceutical Holding Company Ltd. BHVN | director | 470,000 0.1717% | $17.00 | $7.99M | |||
| 2015-10-13 | Aclaris Therapeutics, Inc. ACRS | director | 909,090 4.5006% | $11.00 | $10M | +61.56% | ||
| 2015-10-07 | Aclaris Therapeutics, Inc. ACRS | director | 26,704 0.1491% | $11.00 | $293,744 | +81.54% | ||
| 2015-04-14 | KalVista Pharmaceuticals, Inc. KALV | director | 2.02M 7.8161% | $5.00 | $10.13M | -23.08% |